281 related articles for article (PubMed ID: 6603478)
41. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE
Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
[TBL] [Abstract][Full Text] [Related]
42. The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.
Levine CR; Gewolb IH; Allen K; Welch RW; Melby JM; Pollack S; Shaffer T; Pilon AL; Davis JM
Pediatr Res; 2005 Jul; 58(1):15-21. PubMed ID: 15774846
[TBL] [Abstract][Full Text] [Related]
43. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
44. Inhibitors of elastase in airway lavage samples from ventilated preterm human neonates.
Griese M; Pudenz P; Gebhard W
Am J Respir Crit Care Med; 1998 Jul; 158(1):256-62. PubMed ID: 9655738
[TBL] [Abstract][Full Text] [Related]
45. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
[TBL] [Abstract][Full Text] [Related]
46. Enzyme-linked immunoassay for human granulocyte elastase in complex with alpha 1-proteinase inhibitor.
Neumann S; Hennrich N; Gunzer G; Lang H
Adv Exp Med Biol; 1984; 167():379-90. PubMed ID: 6608861
[TBL] [Abstract][Full Text] [Related]
47. Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.
Perlmutter DH; Travis J; Punsal PI
J Clin Invest; 1988 Jun; 81(6):1774-80. PubMed ID: 3260245
[TBL] [Abstract][Full Text] [Related]
48. Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency.
Dean RT; Nick HP; Schnebli HP
Biochem Biophys Res Commun; 1989 Mar; 159(2):821-7. PubMed ID: 2784675
[TBL] [Abstract][Full Text] [Related]
49. The elastase inhibitory capacity and the alpha 1-proteinase inhibitor and bronchial inhibitor content of bronchoalveolar lavage fluids from healthy subjects.
Boudier C; Pelletier A; Gast A; Tournier JM; Pauli G; Bieth JG
Biol Chem Hoppe Seyler; 1987 Aug; 368(8):981-90. PubMed ID: 3311075
[TBL] [Abstract][Full Text] [Related]
50. Interference of cartilage surface with interaction of granulocyte elastase with alpha 1-proteinase inhibitor. An in vitro model of enzyme inhibition in the joint space.
Burkhardt H; Kasten M; Rauls S; Rehkopf E
Rheumatol Int; 1987; 7(3):133-8. PubMed ID: 3313660
[TBL] [Abstract][Full Text] [Related]
51. Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples.
Morrison HM; Kramps JA; Dijkman JH; Stockley RA
Thorax; 1986 Jun; 41(6):435-41. PubMed ID: 3491440
[TBL] [Abstract][Full Text] [Related]
52. [Neutrophil elastase and alpha 1-proteinase inhibitor in the gingival fluid of patients with inflammatory diseases of the periodontium].
Borovskiĭ EV; Paskhina TS; Pustovoĭt EV; Platonova LV; Kocherzhinskiĭ VV
Stomatologiia (Mosk); 1988; 67(3):25-7. PubMed ID: 3046061
[No Abstract] [Full Text] [Related]
53. alpha1-Proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial.
Stiskal JA; Dunn MS; Shennan AT; O'Brien KK; Kelly EN; Koppel RI; Cox DW; Ito S; Chappel SL; Rabinovitch M
Pediatrics; 1998 Jan; 101(1 Pt 1):89-94. PubMed ID: 9417158
[TBL] [Abstract][Full Text] [Related]
54. Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia.
Kojima T; Sasai M; Kobayashi Y
Lancet; 1993 Oct; 342(8878):1023-4. PubMed ID: 8105265
[TBL] [Abstract][Full Text] [Related]
55. [Elastolytic activity of bronchoalveolar lavage fluid in acute lung inflammatory injury].
Kubyshkin AV; Fomochkina II
Ukr Biokhim Zh (1999); 2008; 80(1):89-95. PubMed ID: 18710032
[TBL] [Abstract][Full Text] [Related]
56. Determination of elastase inhibitory activity of alpha 1-proteinase inhibitor and bronchial antileukoprotease: different results using insoluble elastin or synthetic low molecular weight substrates.
Kramps JA; Morrison HM; Burnett D; Dijkman JH; Stockley RA
Scand J Clin Lab Invest; 1987 Jun; 47(4):405-10. PubMed ID: 2440098
[TBL] [Abstract][Full Text] [Related]
57. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage.
Stockley RA; Morrison HM; Smith S; Tetley T
Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053
[TBL] [Abstract][Full Text] [Related]
58. Functional and immunoreactive alpha 1 proteinase inhibitor in bronchoalveolar lavages: methodological studies.
el Yamani J; Hayem A; Lafitte JJ; Gressier B; Mizon J
Bull Eur Physiopathol Respir; 1986; 22(4):359-63. PubMed ID: 3094607
[TBL] [Abstract][Full Text] [Related]
59. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
Pierce MR; Bancalari E
Pediatr Pulmonol; 1995 Jun; 19(6):371-8. PubMed ID: 7567218
[No Abstract] [Full Text] [Related]
60. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
